This cross-sectional study compares the degree of atherogenesis based on subclinical parameters as cIMT, the presence of atherosclerosis plaque, and early inflammatory markers (CRP, IL-6, MCP1, and sICAM-1) in recent-onset PsA patients, low-intermediate CPs patients (control group accounting for inflammatory setting), and healthy subjects. This evidence concerns the gene CCL2 and atherosclerosis.